Home » Prescription Drugs 7 » Famox Pepcid
Indications:1.Duodenal ulcer 2.Benign gastric ulcer 3.Hypersecretory conditions such as Zollinger-Ellison syndrome 4.Prevention of relapses of duodenal ulceration 5.Prevention of relapses of benign gastric ulcer 6.Symptomatic relief of gastroesophageal reflux disease. 7.Healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease 8.Prevention of relapses of symptoms and erosions or ulcerations associated with GERD. Dosage and AdministrationDuodenal Ulcer:Initial Therapy: The recommended dose of famotidine is one 40mg tablet daily taken at night. Treatment should be given for four to eight weeks but the duration of treatment may be shortened if endoscopy reveals that the ulcer has healed. In most cases of duodenal ulcer healing occurs within four weeks on this regimen. In those patients whose ulcers have not healed completely after four weeks treatment should be continued for a further four week period.Maintenance Therapy: For the prevention of recurrence of duodenal ulceration it is recommended that therapy with famotidine be continued with a dose of one 20mg tablet daily taken at night.Benign Gastric Ulcer:The recommended dose of famotidine is one 40mg tablet daily taken at night. Treatment should be given for 4-8 weeks but the duration of treatment may be shortened if endoscopy reveals that the ulcer has healed.Maintenance Therapy: For the prevention of recurrence of benign gastric ulcer the recommended dosage is one 20mg tablet taken at night which may be given for up to one year.Zollinger-Ellison Syndrome:Patients without prior antisecretory therapy should be started on a dose of 20mg every 6 hours. Dosage should be adjusted to individual patient needs and should continue for as long as indicated clinically. Doses up to 800mg daily have been used for up to one year without the development of significant adverse effects or tachyphylaxis. Patients who have been receiving another H2-antagonist may be switched directly to famotidine at a starting dose higher than that recommended for new cases; this starting dose will depend on the severity of the condition and the last dose of the H2-antagonist previously used.Gastroesophageal Reflux Disease:The recommended dosage for the symptomatic relief of gastroesophageal reflux disease is 20mg of famotidine twice daily.For the treatment of oesophageal erosion or ulceration associated with GERD the recommended dosage is 40mg of famotidine twice daily.Maintenance Therapy: For the prevention of recurrence of symptoms and erosions or ulcerations associated with GERD the recommended dosage is 20mg of famotidine twice daily.Dosage Adjustment for Patients with Severe Renal Insufficiency:In adult patients with moderate (creatinine clearance <50mL/min) or severe (creatinine clearance <10mL/min) renal insufficiency the elimination half-life of famotidine is increased. For patients with severe renal insufficiency it may exceed 20 hours reaching approximately 24 hours in anuric patients. Since CNS adverse effects have been reported in patients with moderate and severe renal insufficiency to avoid excess accumulation of the medicine in patients with moderate and severe renal insufficiency the dose of famotidine may be reduced to half the dose or the dosing interval may be prolonged to 36-48 hours as indicated by the patient's clinical response
Buy Famox Pepcid and other Prescription Drugs 7 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Famox Pepcid:
Product Type: Prescription Drugs 7
Famox ( Pepcid Generic Famotidine )
Famox (Pepcid Generic Famotidine)
Pepcid Generic Famotidine
20mg 40mg 250 Tablets 500(2 x 250) Tablets
Pepcid Generic Famotidine Famox

View more
Prescription Drugs 7
Previous Product Next Product
You do not need a prescription to buy our products as we work under the laws of the country we ship from. We do recommend you check with your local customs to see if it is okay to import these products.
Errors and Omissions. We are not responsible for any typographical errors or inaccuracies set forth in this website. The information, prices, and discounts set forth herein are subject to change without notice.
Product Fulfilment : The pharmacy / Fulfilment Centre cannot be held liable for the accuracy of the diagnosis, treatment or medication prescribed or the correct use of products supplied. It lies on the purchaser to use any products supplied under the guidance of a physician.
Product Quality. The Pharmacy / Fulfilment Centre is responsible for ensuring that the correct product, in the correct amount and the correct strength is supplied to the correct patient. Product liability lies solely with the manufacturer.
World Drug News. Government funding crisis in Swaziland disrupts supply of HIV/AIDS supplies. "An acute government funding crisis in Swaziland, Africa's last absolute monarchy, is disrupting supplies of HIV/AIDS drugs and hampering the fight against the virus in the country with the world's highest infection rate, Medecins Sans Frontieres (MSF) said Friday," Reuters reports. "Stocks of testing kits and related chemicals were 'almost dry,' making it next-to-impossible to chart the progress of the 70,000 patients on therapy or more than 130,000 other people carrying the virus, the aid agency said," according to Reuters.
"With 26 percent of its adult population, or more than 200,000 people infected, Swaziland ranks as the most AIDS-affected country," Reuters writes (Cropley, (9/9). In related news, a new report from Swaziland's government "has found that more than half of [30,000 Swazis, mostly women, working] in Swaziland's garment industry are living with HIV, and officials are realizing that the once-hailed promise of manufacturing employment has become a financial and medical nightmare for tens of thousands of Swazi women," PlusNews reports (8/11).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
Glez Glucotrol
Gliben Daonil
Gliclazide Glyade
Glimax Amaryl
Glimy Amaryl
GLINATE Starlix
Glinil M Glucovance
GlucoBalance
Glucobay Precose
Glucophage Fortamet
Glucophage (Metformin)
Glucotrol (Glipizide SR)
Glucotrol XL Generic Glipizide
Glucovance Generic Glyburide
GLUMET Glucophage
Glynase Glucotrol
Glynase XL Glucotrol XL
Gonaphene Clomid
GRANICIP KYTRIL
Graniset Kytril
Grief & Pining Formula
Grisactin (Griseofulvin)
GRISOVIN Fulvicin


|